Patient Pathfinder: Clinical Trials

Clinical Trial Finder AL Amyloidosis Trials

Clinical Trials for AL Amyloidosis

See Locations Near You

There are 21 active AL Amyloidosis trials

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Study Type: Interventional Phase 1

Amyloidosis Incidence in High-Risk Cardiac Device Patients

Study Type: Observational

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Study Type: Interventional Phase 1

Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders

Study Type: Observational

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Study Type: Interventional Phase 1

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Study Type: Interventional Phase 1

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Study Type: Interventional Phase 2

Ixazomib Maintenance Study in Patients With AL Amyloidosis

Study Type: Interventional Phase 2

There are 21 active AL Amyloidosis trials

Filter Results

Phase

Study Type

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider